Versant Venture Capital V, L.P's Net Worth
Versant Venture Capital V, L.P's net worth is estimated to be at least $1,164,662.59 as of 11/23/2024. CoreStreet's estimation of Versant Venture Capital V, L.P's net worth is based on their sale of stock and current holding of stock.
Versant Venture Capital V, L.P is Major Shareholder at Crispr Therapeutics AG. They have executed at least 1 trades of stock as per SEC Form 4 filings. Their most recent trade was for 22,841 units of CRSP stock on 04/24/2018. Their biggest sale was on 04/24/2018 when they sold 22,841 units of Crispr Therapeutics AG stock for $1,164,662.59. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $1,164,662.59
Most recent insider trade:
- April 24, 2018
Versant Venture Capital V, L.P's Insider Trading History
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 24, 2018 | Major Shareholder | 22,841 | $50.99 | Sell | $1,164,662.59 |